Lefs Score Calculator
Calculate the Lower Extremity Functional Scale score for leg and hip function assessment. Enter values for instant results with step-by-step formulas.
Formula
LEFS = Sum of 20 items (each scored 0-4)
Each of the 20 questions is scored from 0 (extreme difficulty or unable) to 4 (no difficulty). Total score ranges from 0 to 80, with higher scores indicating better lower extremity function. MCID is approximately 9-12 points.
Worked Examples
Example 1: Post-ACL Reconstruction at 3 Months
Problem: A 28-year-old athlete is 3 months post ACL reconstruction. They can perform basic daily activities with little difficulty but have moderate difficulty with stairs and walking long distances, and cannot yet run or hop.
Solution: ADL items (10 items): avg 3.5 = 35/40\nMobility items (5 items): avg 2.0 = 10/20\nHigh-demand items (5 items): avg 0.5 = 2.5/20 (round to 3)\nTotal LEFS = 35 + 10 + 3 = 48/80\nPercentage: 60% of maximum function
Result: LEFS Score: 48/80 (Moderate Limitation) - Expected at 3 months post-ACL; high-demand activities remain significantly limited
Example 2: Hip Osteoarthritis Pre-Treatment Assessment
Problem: A 65-year-old patient with moderate hip osteoarthritis has difficulty with prolonged walking, stairs, and squatting. Basic room-to-room walking and sitting are manageable with mild difficulty.
Solution: ADL items (10 items): avg 2.5 = 25/40\nMobility items (5 items): avg 1.5 = 7.5/20 (round to 8)\nHigh-demand items (5 items): avg 0.5 = 2.5/20 (round to 3)\nTotal LEFS = 25 + 8 + 3 = 36/80\nPercentage: 45% of maximum function
Result: LEFS Score: 36/80 (Moderate Limitation) - Significant functional deficit indicating need for intervention
Frequently Asked Questions
What is the LEFS and what does it measure?
The Lower Extremity Functional Scale (LEFS) is a 20-item patient-reported outcome measure designed to assess the functional status of patients with disorders of the lower extremity including the hip, knee, ankle, and foot. It was developed by Binkley, Stratford, Lott, and Riddle and published in 1999 as a clinically practical and psychometrically sound instrument. Each item is scored from 0 (extreme difficulty or unable to perform) to 4 (no difficulty), giving a total score range of 0 to 80 points. Higher scores indicate greater functional ability, and the LEFS can be used across a wide range of lower extremity conditions from post-surgical rehabilitation to chronic degenerative joint disease.
How is the LEFS score calculated and interpreted?
The LEFS score is calculated by simply summing the responses to all 20 questions, where each item is scored from 0 (extreme difficulty) to 4 (no difficulty). The maximum possible score is 80, representing no functional limitation in the lower extremity. Scores below 35 generally indicate significant functional limitation requiring active intervention, while scores above 65 suggest minimal limitation consistent with near-normal function. The minimal detectable change (MDC) for the LEFS is 9 points, meaning a change of at least 9 points is required to be confident that a real change in function has occurred. The minimal clinically important difference (MCID) is approximately 9 to 12 points.
What conditions is the LEFS appropriate for assessing?
The LEFS was designed and validated for use across all musculoskeletal conditions affecting the lower extremity, making it versatile compared to joint-specific measures. It is commonly used for knee osteoarthritis, hip osteoarthritis, knee ligament injuries (ACL tears), meniscal injuries, ankle sprains and fractures, hip fractures, lower limb arthroplasty assessment, and general lower limb rehabilitation. The broad applicability of the LEFS is one of its primary advantages because it allows comparison of functional outcomes across different conditions and anatomical sites. However, for conditions where very specific joint function is critical, supplementing the LEFS with a joint-specific measure may provide additional clinically useful information.
How does the LEFS compare to the WOMAC for lower extremity assessment?
The LEFS and WOMAC (Western Ontario and McMaster Universities Arthritis Index) are both widely used for lower extremity assessment but differ in important ways that affect their clinical applicability. The WOMAC was specifically designed for hip and knee osteoarthritis and includes separate subscales for pain, stiffness, and physical function, providing more detailed information about these specific domains. The LEFS is a single-construct measure of overall function that can be applied to any lower extremity condition, not just arthritis, making it more versatile in clinical practice. Studies comparing the two instruments show similar responsiveness to change after joint replacement, but the LEFS is simpler to score and has fewer items.
What is the minimal clinically important difference for the LEFS?
The minimal clinically important difference (MCID) for the LEFS has been established at approximately 9 to 12 points through multiple studies using different anchor-based and distribution-based methods. This means that a change of 9 points or more on the LEFS can be considered a clinically meaningful improvement or deterioration from the patient perspective. The minimal detectable change at the 90% confidence level (MDC90) is approximately 9 points, which represents the smallest change that exceeds measurement error. When evaluating treatment outcomes, clinicians should look for changes exceeding the MCID to determine whether an intervention has produced a meaningful functional improvement for the patient.
Can the LEFS be used for both surgical and non-surgical patients?
The LEFS is validated for use in both surgical and non-surgical patient populations with lower extremity conditions and performs well across this full clinical spectrum. For surgical patients, it is commonly administered pre-operatively to establish baseline function and then at regular post-operative intervals to track recovery trajectory over time. In non-surgical patients, the LEFS helps monitor the effectiveness of conservative treatments such as physical therapy, medication management, and activity modification programs. The instrument shows good responsiveness in both surgical and non-surgical populations, though ceiling effects may occur in highly functional patients such as athletes returning to sport who score near the maximum before achieving their full pre-injury capabilities.